These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 323904)
21. Factors affecting the sensitivity of self-rating scales [proceedings]. Keller R; Rada RT; Pathak D Psychopharmacol Bull; 1978 Jul; 14(3):63-5. PubMed ID: 674540 [No Abstract] [Full Text] [Related]
22. Time-blind evaluation of psychopathology in drug research. Bobon DP Acta Psychiatr Belg; 1978; 78(4):635-45. PubMed ID: 362829 [TBL] [Abstract][Full Text] [Related]
23. The role of rating scales in the identification and management of the depressed patient in the primary care setting. Zung WW J Clin Psychiatry; 1990 Jun; 51 Suppl():72-6. PubMed ID: 2189877 [TBL] [Abstract][Full Text] [Related]
24. Content analysis of 27 anxiety inventories and rating scales. de Bonis M Mod Probl Pharmacopsychiatry; 1974; 7(0):221-37. PubMed ID: 4153303 [No Abstract] [Full Text] [Related]
25. Bromazepam and phenobarbital in anxiety: a controlled study. Rickels K; Pereira-Ogan JA; Chung HR; Gordon PE; Landis WB Curr Ther Res Clin Exp; 1973 Oct; 15(10):679-90. PubMed ID: 4201312 [No Abstract] [Full Text] [Related]
26. Diazepam and phenobarbital in the treatment of anxiety: a controlled multicenter study using physician and patient rating scales. Cohen J; Gomez E; Hoell NL; Kotin J; Rickman EE; Roessler RL Curr Ther Res Clin Exp; 1976 Aug; 20(2):184-93. PubMed ID: 821719 [No Abstract] [Full Text] [Related]
27. The rating and self-rating of anxiety. Kellner R; Uhlenhuth EH Br J Psychiatry Suppl; 1991 Sep; (12):15-22. PubMed ID: 1840759 [TBL] [Abstract][Full Text] [Related]
28. Controlled evaluation of the beta adrenoceptor blocking drug oxprenolol in anxiety. Johnson G; Singh B; Leeman M Med J Aust; 1976 Jun; 1(24):909-12. PubMed ID: 790112 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of trazodone in the treatment of anxiety. Wheatley D Curr Ther Res Clin Exp; 1976 Jul; 20(1):74-83. PubMed ID: 821709 [No Abstract] [Full Text] [Related]
30. [Double-blind trial treatment of anxiety with b 5833]. Cloquette R Acta Psychiatr Belg; 1974 May; 74(3):317-26. PubMed ID: 4156149 [No Abstract] [Full Text] [Related]
31. Scales of potential use in the psychopharmacologic treatment of depressed children and adolescents. Petti TA Psychopharmacol Bull; 1985; 21(4):951-77. PubMed ID: 4089114 [No Abstract] [Full Text] [Related]
33. Amoxapine: a clinical evaluation in depressive syndromes. Charalampous KD Curr Ther Res Clin Exp; 1972 Oct; 14(10):657-63. PubMed ID: 4628808 [No Abstract] [Full Text] [Related]
34. A new rating scale for evaluating clinical response in psychoneurotic outpatients. Free SM; Guthrie MB J Clin Pharmacol J New Drugs; 1969; 9(3):187-94. PubMed ID: 5255182 [No Abstract] [Full Text] [Related]
35. Methodological considerations in evaluating antianxiety drugs. Hollister LE J Clin Pharmacol J New Drugs; 1970; 10(1):12-8. PubMed ID: 4903952 [No Abstract] [Full Text] [Related]
36. [The measurement of anxiety by the questionnaire method. Methodological problems]. Pichot P; de Bonis M Schweiz Arch Neurol Neurochir Psychiatr; 1971; 109(1):111-23. PubMed ID: 5142840 [No Abstract] [Full Text] [Related]
37. Pilot open-label study of lenperone (AHR 2277), a butyrophenone, in anxiety. Fabre LF; Harris RT Curr Ther Res Clin Exp; 1976 Mar; 19(3):328-31. PubMed ID: 817861 [No Abstract] [Full Text] [Related]
38. Comparisons of results of different patient evaluation methods in clinical psychopharmacology. Esser AH; Flegel H Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):292-5. PubMed ID: 4903987 [No Abstract] [Full Text] [Related]